Brief: Axovant Gene Therapies Receives Rare Pediatric Disease Designation For AXO-AAV-GM2 For Tay-Sachs And Sandhoff Disease

Sio Gene Therapies

13/10/2020 12:43

Oct 13 (Reuters) - Axovant Gene Therapies Ltd  AXGT.O :
    * AXOVANT GENE THERAPIES RECEIVES RARE PEDIATRIC DISEASE
DESIGNATION FOR AXO-AAV-GM2 FOR TAY-SACHS AND SANDHOFF DISEASE
    * AXOVANT GENE THERAPIES - EXPECTS TO EVALUATE AXO-AAV-GM2
IN
REGISTRATIONAL TRIAL CONSISTING OF STAGE 1 DOSE-RANGING STUDY,
STAGE 2 EFFICACY STUDY

Source text for Eikon:  ID:nGNX1ShSyY 
Further company coverage:  AXGT.O 

 ((Reuters.Briefs@thomsonreuters.com;))